Levosiz M Tablet 15

Levosiz M tablet can interact with Medications, including

• CNS Depressants: Levosiz M tablets may increase the sedative effects of other CNS depressants such as alcohol, opioids, barbiturates, and benzodiazepines, leading to increased drowsiness and dizziness. Co-administration of Levosiz M tablets with these drugs should be avoided, or the dosage should be adjusted accordingly.
• Ketoconazole: Ketoconazole may increase the levels of Levosiz M tablets in the body, leading to an increased risk of side effects. Patients taking ketoconazole should use Levosiz M tablets cautiously, and a lower dosage or increased dosing interval may be required.
• Rifampin: Rifampin may decrease the levels of Levosiz M tablets in the body, leading to a decreased therapeutic effect. Patients taking rifampin should use Levosiz M tablets cautiously, and a higher dosage may be required.
• Antihistamines: Co-administration of Levosiz M tablets with other antihistamines may increase the risk of side effects such as drowsiness, dizziness, and blurred vision. Patients should avoid using other antihistamines while taking Levosiz M tablets.
• Erythromycin: Erythromycin may increase the levels of Levosiz M tablets in the body, leading to an increased risk of side effects. Patients taking erythromycin should use Levosiz M tablets cautiously, and a lower dosage or increased dosing interval may be required.
• MAO inhibitors: Levosiz M tablets should not be taken with MAO inhibitors, as they may increase serotonin syndrome risk. This potentially life-threatening condition may occur due to excessive serotonin levels.

The Levosiz M tablet can interact with Diseases, including

• Liver disease: Levosiz M tablets are metabolised in the liver. Patients with liver disease may be unable to clear the medication from their bodies, leading to increased side effects. Patients with liver disease should use Levosiz M tablets cautiously, and a lower dosage or increased dosing interval may be required.
• Kidney disease: Levosiz M tablets are excreted through the kidneys, and patients with kidney disease may be unable to eliminate the medication from their kidneys, leading to increased side effects. Patients with kidney disease should use Levosiz M tablets cautiously, and a lower dosage or increased dosing interval may be required.
• Cardiovascular: Levosiz M tablets may cause cardiovascular side effects such as palpitations, chest pain, and irregular heartbeat. Patients with cardiovascular disease should use Levosiz M tablets with caution and under the supervision of a healthcare provider.
• Seizure disorder: Levosiz M tablets may lower the seizure threshold and increase the risk of seizures in patients with a history of seizure disorder. Patients with a seizure disorder should use Levosiz M tablets with caution and under the supervision of a healthcare provider.
• Glaucoma: Levosiz M tablets may increase intraocular pressure and worsen the symptoms of glaucoma. Patients with glaucoma should use Levosiz M tablets with caution and under the supervision of an ophthalmologist.

The recommended daily dose of Levosiz M tablet is once daily, with or without food, as directed by your doctor. The dosage may change based on individual factors such as the severity of the condition and response to treatment. Following the prescribed dosage and consulting your doctor before exceeding it is essential.

If you or someone else takes an excessive amount of Levosiz M tablet by accident, it is essential to take immediate medical attention from your doctor or nearby hospital. Symptoms of an overdose include headache, drowsiness, dry mouth, nausea, fatigue, dizziness, diarrhoea, abdominal pain, vomiting, agitation, restlessness, and blurred vision. 

If you miss a dose of Levosiz M tablet, take it as soon as you remember. If the time for the next dosage is close, skipping the missed one is recommended now and resume your regular dosage pattern. Consult your doctor before increasing your dosage.